463 related articles for article (PubMed ID: 19615945)
1. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Anand SP; Selvaraj P
Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
[TBL] [Abstract][Full Text] [Related]
2. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis.
Prabhu Anand S; Selvaraj P; Narayanan PR
Cytokine; 2009 Feb; 45(2):105-10. PubMed ID: 19091593
[TBL] [Abstract][Full Text] [Related]
3. 1, 25 Dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis.
Vidyarani M; Selvaraj P; Jawahar MS; Narayanan PR
Cytokine; 2007 Nov; 40(2):128-34. PubMed ID: 17911026
[TBL] [Abstract][Full Text] [Related]
4. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.
Kuyvenhoven JP; Molenaar IQ; Verspaget HW; Veldman MG; Palareti G; Legnani C; Moolenburgh SE; Terpstra OT; Lamers CB; van Hoek B; Porte RJ
Thromb Haemost; 2004 Mar; 91(3):506-13. PubMed ID: 14983226
[TBL] [Abstract][Full Text] [Related]
5. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
[TBL] [Abstract][Full Text] [Related]
6. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
[TBL] [Abstract][Full Text] [Related]
7. Regulatory role of 1, 25-dihydroxyvitamin D3 and vitamin D receptor gene variants on intracellular granzyme A expression in pulmonary tuberculosis.
Vidyarani M; Selvaraj P; Raghavan S; Narayanan PR
Exp Mol Pathol; 2009 Feb; 86(1):69-73. PubMed ID: 19014932
[TBL] [Abstract][Full Text] [Related]
8. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro.
Asano K; Kanai KI; Suzaki H
Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma gene +874A/T polymorphism and intracellular interferon gamma expression in pulmonary tuberculosis.
Prabhu Anand S; Harishankar M; Selvaraj P
Cytokine; 2010 Feb; 49(2):130-3. PubMed ID: 20004112
[TBL] [Abstract][Full Text] [Related]
10. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
Florys B; Głowińska B; Urban M; Peczyńska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
[TBL] [Abstract][Full Text] [Related]
11. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro.
Shimizu T; Kanai K; Kyo Y; Asano K; Hisamitsu T; Suzaki H
J Pharm Pharmacol; 2006 Jan; 58(1):91-9. PubMed ID: 16393468
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.
Gilli F; Bertolotto A; Sala A; Hoffmann F; Capobianco M; Malucchi S; Glass T; Kappos L; Lindberg RL; Leppert D
Brain; 2004 Feb; 127(Pt 2):259-68. PubMed ID: 14607790
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma.
Mautino G; Henriquet C; Gougat C; Le Cam A; Dayer JM; Bousquet J; Capony F
Lab Invest; 1999 Jan; 79(1):39-47. PubMed ID: 9952109
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
[TBL] [Abstract][Full Text] [Related]
15. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and their tissue inhibitors in multiple sclerosis.
Ozenci V; Rinaldi L; Teleshova N; Matusevicius D; Kivisäkk P; Kouwenhoven M; Link H
J Autoimmun; 1999 Jun; 12(4):297-303. PubMed ID: 10330301
[TBL] [Abstract][Full Text] [Related]
18. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
19. Production of matrix metalloproteinases and their inhibitors in osteoarthritic patients undergoing mud bath therapy.
Bellometti S; Richelmi P; Tassoni T; Bertè F
Int J Clin Pharmacol Res; 2005; 25(2):77-94. PubMed ID: 16060398
[TBL] [Abstract][Full Text] [Related]
20. [Correlation between tumor necrosis factor alpha and matrix metalloproteinases levels in serum of patients with rheumatic arthritis].
Klimiuk PA; Sierakowski S; Chwiećko J
Pol Merkur Lekarski; 2003 May; 14(83):410-2. PubMed ID: 12939814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]